mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.2 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.059 |
0.2 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |